WITHDRAWAL OF MAGNESIUM ENHANCES CORONARY ARTERIAL SPASMS PRODUCED BY VASOACTIVE AGENTS
- 1 December 1982
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 77 (4) , 649-659
- https://doi.org/10.1111/j.1476-5381.1982.tb09343.x
Abstract
The influence of external magnesium ions ([Mg2+]o) on the sensitivity (i.e., EC50 [median effective concentration]) and contractility (maximum response) of isolated large and small coronary arteries of the dog, obtained from different regions of the myocardium, to vascoactive agents were studied. Removal of [Mg2+]o from the physiological salt solution enhanced, while elevation in [Mg2+]o to 4.8 mM, lowered the contractile sensitivity to 3 different agents, 5-hydroxytryptamine (5-HT), angiotensin II and KCl. Contractility, of both large and small coronary arteries, to 5-HT and angiotensin II was potentiated and depressed, respectively, by withdrawal and elevation of [Mg2+]o; maximum responses to KCl were not altered by 0 or 4.8 mM [Mg2+]o. Cumulative concentration-contractile effect curves to CaCl2 were shifted leftward on removal of [Mg2+]o; elevation of [Mg2+]o to 4.8 mM shifted the CaCl2 concentration-effect curves to the right. Maximal contractile responses to CaCl2 were enhanced by removal of, and reduced by elevation of, [Mg2+]o. The Ca channel blocking agent, verapamil (10-6 M), inhibited completely contractile responses to KCl; contractile responses elicited by angiotensin II and 5-HT were attenuated by verapamil. A variety of pharmacological antagonists (phentolamine, propranolol, methysergide, atropine and diphenhydramine), as well as use of a prostaglandin cyclo-oxygenase inhibitor [indomethacin], did not modify the altered contractile responses evoked by angiotensin II or KCl in different concentrations of Mg2+. These results suggest the following: [Mg2+]o may exert considerably greater influence on receptor-operated rather than membrane-potential sensitive channels involved in Ca2+ transport in coronary arterial smooth muscle; Mg2+ interferes with the affinity (binding) of certain agonists (5-HT and angiotensin II) for their respective receptors in coronary vascular muscle; and a functional pool of Ca2+ which is resistant to Ca2+-depletion, but accessible to activation by 5-HT and angiotensin II is present in canine coronary arterial smooth muscle.This publication has 32 references indexed in Scilit:
- Type-A behavior and coronary vasospasm: A possible role of hypomagnesemiaMedical Hypotheses, 1980
- Is interferon produced in physiologic conditions?Medical Hypotheses, 1980
- Magnesium Deficiency Produces Spasms of Coronary Arteries: Relationship to Etiology of Sudden Death Ischemic Heart DiseaseScience, 1980
- Sudden-death ischemic heart disease and dietary magnesium intake: Is the target site coronary vascular smooth muscle?Medical Hypotheses, 1979
- Extracellular magnesium ions control calcium exchange and content of vascular smooth muscleEuropean Journal of Pharmacology, 1978
- Magnesium and Vascular Tone and ReactivityJournal of Vascular Research, 1978
- The importance of magnesium deficiency in cardiovascular diseaseAmerican Heart Journal, 1977
- Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: Documentation by coronary arteriographyAmerican Heart Journal, 1976
- Magnesium and contraction of arterial smooth muscleMicrovascular Research, 1974
- The effect of calcium and magnesium ions on drug-receptor interactionsEuropean Journal of Pharmacology, 1972